CH311606A - Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). - Google Patents

Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).

Info

Publication number
CH311606A
CH311606A CH311606DA CH311606A CH 311606 A CH311606 A CH 311606A CH 311606D A CH311606D A CH 311606DA CH 311606 A CH311606 A CH 311606A
Authority
CH
Switzerland
Prior art keywords
anilide
methyl
butyl
chloro
amine
Prior art date
Application number
Other languages
German (de)
Inventor
Aktiengesellschaft Cilag
Original Assignee
Cilag Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cilag Ag filed Critical Cilag Ag
Publication of CH311606A publication Critical patent/CH311606A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Description

  

  



  Verfahren zur Herstellung eines neuen basisch substituierten   Fettsäure-     (2-halogen-6-methyl-anilids).



   Gegenstand des vorliegenden Patentes bil (let ein Verfahren zur Herstellung eines neuen   basiseli substituierten Fettsäure- (2-halogen-6-      methyl-anilids),    welches   dadurch gekennzeich-    net ist, dass man eine Verbindung der Formel
EMI1.1     
 in welcher X einen reaktionsfähigen, während der Reaktion sich   abspaltenden    Rest bedeutet, mit Di-n-butyl-amin umsetzt.



   Der Rest X kann in einem Halogenatom oder einem sonstigen für den Austausch gegen den basischen Rest geeigneten reaktionsfähigen Substituenten, wie z. B. e-iner   Alkylsulfo-    nyloxy-oder Arylsulfonyloxygruppe, bestehen.



  Der Austausch der Gruppe X gegen den Di  n-butyl-aminrest erfolgt    z. B. durch einfaches   Erwärmen    mit   Di-n-butyl-amin gegebenen-    falls in Gegenwart eines basisch reagierenden Kondensationsmittels oder von   Di-n-butyl-    amin   im Überschu#. Das Di-n-butyl-aminoacet-      (2-ehlor-6-methyl-anilid)    ist ein farbloses, unter 0,   06 mm    Hg bei 145  siedendes Öl. Das   Hydroehlorid    der Base schmilzt bei   145    bis   1470.   



   Das neue Anilid soll als   Lokalanästhetikum    und als Zwischenprodukt zur Herstellung weiterer Derivate Verwendung finden.



   Beispiel :
31 Gewichtsteile   Chloracet- (2-chlor-6-me-      thyl-a. nilid)    (gewonnen durch Umsetzen von 2  Chlor-6-methyl-anüin    mit Chloracetylchlorid in Gegenwart von   Natriumacetat, Schmp.    140 bis   141 )    werden in 80 Gewichtsteilen Äthanol suspendiert und mit. 55 Gewichtsteilen Di-n  butyl-amin versetzt.    Die Temperatur steigt dabei leicht an und ein grosser Teil des Reak  tionsgemisches    geht in   Losung.    Nun wird während 4 Stunden bei Zimmertemperatur gerührt und dann einige Stunden bei   65-75 .   



  Eine Probe mit Wasser und nachfolgend mit verdünnter Salzsäure versetzt ergibt wieder Lösung des ausgefallenen Niederschlages. Mit Wasserdampf wird hierauf der Alkohol und das übersehüssige   Di-n-butyl-amin    abgeblasen und nach dem Erkalten das zurückbleibende Öl in Äther aufgenommen. Naeh dem Trocknen der   ätherischen Losung    und Verjagen des   Losungsmittels    verbleibt ein   01,    das durch Vakuumdestillation gereinigt wird. Man erhält 43 Gewichtsteile reines   Di-n-butyl-aminoacet-      (2-chlor-6-methyl-anilid).    Die Umsetzung mit   Di-n-butyl-amin kann aneh    in Benzol stattfinden.  



   PATENTANSPRUCH :
Verfahren zur Herstellung eines neuen basisch substituierten Fettsäure-(2-halogen-6methyl-anilids), dadureh gekennzeichnet, dass man eine Verbindung der Formel 

**WARNUNG** Ende DESC Feld konnte Anfang CLMS uberlappen**.





  



  Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).



   The subject of the present patent bil (let a process for the production of a new basiseli substituted fatty acid (2-halogen-6-methyl-anilide), which is characterized in that a compound of the formula
EMI1.1
 in which X is a reactive radical which is split off during the reaction, is reacted with di-n-butylamine.



   The radical X can be in a halogen atom or any other reactive substituent suitable for replacement with the basic radical, such as. B. e-iner alkylsulfonyloxy or arylsulfonyloxy group exist.



  The exchange of the group X against the di n-butyl-amine residue takes place, for. B. by simply heating with di-n-butyl-amine, if necessary in the presence of a basic condensing agent or an excess of di-n-butyl-amine. Di-n-butyl-aminoacet- (2-chloro-6-methyl-anilide) is a colorless oil boiling below 0.06 mm Hg at 145. The hydrochloride of the base melts at 145 to 1470.



   The new anilide is to be used as a local anesthetic and as an intermediate product for the production of further derivatives.



   Example:
31 parts by weight of chloroacet- (2-chloro-6-methyl-a. Nilide) (obtained by reacting 2 chloro-6-methyl-anuine with chloroacetyl chloride in the presence of sodium acetate, melting point 140 to 141) are in 80 parts by weight of ethanol suspended and with. 55 parts by weight of di-n-butylamine are added. The temperature rises slightly and a large part of the reaction mixture goes into solution. The mixture is then stirred for 4 hours at room temperature and then for a few hours at 65-75.



  A sample with water and then mixed with dilute hydrochloric acid results in a solution of the precipitate. The alcohol and the excess di-n-butyl-amine are then blown off with steam and, after cooling, the remaining oil is absorbed in ether. After the ethereal solution has dried and the solvent has been driven off, an oil remains which is purified by vacuum distillation. 43 parts by weight of pure di-n-butyl-aminoacet- (2-chloro-6-methyl-anilide) are obtained. The reaction with di-n-butylamine can also take place in benzene.



   PATENT CLAIM:
Process for the preparation of a new basic substituted fatty acid (2-halo-6methyl-anilide), characterized in that one is a compound of the formula

** WARNING ** End of DESC field could overlap beginning of CLMS **.



 

Claims (1)

**WARNUNG** Anfang CLMS Feld konnte Ende DESC uberlappen **. ** WARNING ** Beginning of CLMS field could overlap end of DESC **. Verfahren zur Herstellung eines neuen basisch substituierten Fettsäure- (2-halogen-6-methyl-anilids). Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). Gegenstand des vorliegenden Patentes bil (let ein Verfahren zur Herstellung eines neuen basiseli substituierten Fettsäure- (2-halogen-6- methyl-anilids), welches dadurch gekennzeich- net ist, dass man eine Verbindung der Formel EMI1.1 in welcher X einen reaktionsfähigen, während der Reaktion sich abspaltenden Rest bedeutet, mit Di-n-butyl-amin umsetzt. The subject of the present patent bil (let a process for the production of a new basiseli substituted fatty acid (2-halogen-6-methyl-anilide), which is characterized in that a compound of the formula EMI1.1 in which X is a reactive radical which is split off during the reaction, is reacted with di-n-butylamine. Der Rest X kann in einem Halogenatom oder einem sonstigen für den Austausch gegen den basischen Rest geeigneten reaktionsfähigen Substituenten, wie z. B. e-iner Alkylsulfo- nyloxy-oder Arylsulfonyloxygruppe, bestehen. The radical X can be in a halogen atom or any other reactive substituent suitable for replacement with the basic radical, such as. B. e-iner alkylsulfonyloxy or arylsulfonyloxy group exist. Der Austausch der Gruppe X gegen den Di n-butyl-aminrest erfolgt z. B. durch einfaches Erwärmen mit Di-n-butyl-amin gegebenen- falls in Gegenwart eines basisch reagierenden Kondensationsmittels oder von Di-n-butyl- amin im Überschu#. Das Di-n-butyl-aminoacet- (2-ehlor-6-methyl-anilid) ist ein farbloses, unter 0, 06 mm Hg bei 145 siedendes Öl. Das Hydroehlorid der Base schmilzt bei 145 bis 1470. The exchange of the group X against the di n-butyl-amine residue takes place, for. B. by simply heating with di-n-butyl-amine, if necessary in the presence of a basic condensing agent or an excess of di-n-butyl-amine. Di-n-butyl-aminoacet- (2-chloro-6-methyl-anilide) is a colorless oil boiling below 0.06 mm Hg at 145. The hydrochloride of the base melts at 145 to 1470. Das neue Anilid soll als Lokalanästhetikum und als Zwischenprodukt zur Herstellung weiterer Derivate Verwendung finden. The new anilide is to be used as a local anesthetic and as an intermediate product for the production of further derivatives. Beispiel : 31 Gewichtsteile Chloracet- (2-chlor-6-me- thyl-a. nilid) (gewonnen durch Umsetzen von 2 Chlor-6-methyl-anüin mit Chloracetylchlorid in Gegenwart von Natriumacetat, Schmp. 140 bis 141 ) werden in 80 Gewichtsteilen Äthanol suspendiert und mit. 55 Gewichtsteilen Di-n butyl-amin versetzt. Die Temperatur steigt dabei leicht an und ein grosser Teil des Reak tionsgemisches geht in Losung. Nun wird während 4 Stunden bei Zimmertemperatur gerührt und dann einige Stunden bei 65-75 . Example: 31 parts by weight of chloroacet- (2-chloro-6-methyl-a. Nilide) (obtained by reacting 2 chloro-6-methyl-anuine with chloroacetyl chloride in the presence of sodium acetate, melting point 140 to 141) are in 80 parts by weight of ethanol suspended and with. 55 parts by weight of di-n-butylamine are added. The temperature rises slightly and a large part of the reaction mixture goes into solution. The mixture is then stirred for 4 hours at room temperature and then for a few hours at 65-75. Eine Probe mit Wasser und nachfolgend mit verdünnter Salzsäure versetzt ergibt wieder Lösung des ausgefallenen Niederschlages. Mit Wasserdampf wird hierauf der Alkohol und das übersehüssige Di-n-butyl-amin abgeblasen und nach dem Erkalten das zurückbleibende Öl in Äther aufgenommen. Naeh dem Trocknen der ätherischen Losung und Verjagen des Losungsmittels verbleibt ein 01, das durch Vakuumdestillation gereinigt wird. Man erhält 43 Gewichtsteile reines Di-n-butyl-aminoacet- (2-chlor-6-methyl-anilid). Die Umsetzung mit Di-n-butyl-amin kann aneh in Benzol stattfinden. A sample with water and then mixed with dilute hydrochloric acid results in a solution of the precipitate. The alcohol and the excess di-n-butyl-amine are then blown off with steam and, after cooling, the remaining oil is absorbed in ether. After the ethereal solution has dried and the solvent has been driven off, an oil remains which is purified by vacuum distillation. 43 parts by weight of pure di-n-butyl-aminoacet- (2-chloro-6-methyl-anilide) are obtained. The reaction with di-n-butylamine can also take place in benzene. PATENTANSPRUCH : Verfahren zur Herstellung eines neuen basisch substituierten Fettsäure-(2-halogen-6methyl-anilids), dadureh gekennzeichnet, dass man eine Verbindung der Formel EMI2.1 in welcher X einen reaktionsfähigen, während der Reaktion sich abspaltenden Rest bedeutet, mit Di-n-butyl-amin umsetzt. Das auf diese Weise erhaltene Di-n-butyl-aminoacet- (2-chlor- 6-methyl-anilid) bildet ein farbloses, lmter 0, 06 mm Hg bei 145 siedendes Öl. Das Hydro- chlorid der Base schmilzt bei 145-147 . PATENT CLAIM: Process for the preparation of a new basic substituted fatty acid (2-halo-6methyl-anilide), characterized in that one is a compound of the formula EMI2.1 in which X is a reactive radical which is split off during the reaction, is reacted with di-n-butylamine. The di-n-butyl-aminoacet- (2-chloro-6-methyl-anilide) obtained in this way forms a colorless oil that boils at 0.06 mm Hg at 145. The hydrochloride of the base melts at 145-147. Das neue Anilid soll als Lokalanästhetikum und als Zwischenprodukt Verwendung finden. The new anilide will be used as a local anesthetic and as an intermediate product. UNTERANSPRUCH : Verfahren nach Patentanspruch, dadurch gekennzeichnet, da# man ein Halogenacet-(2- ehlor-6-methyl-anilid) mit Di-n-butyl-amin re agieren @ä#t. SUBClaim: Process according to patent claim, characterized in that a haloacet (2-chloro-6-methyl-anilide) is reacted with di-n-butyl-amine.
CH311606D 1952-02-25 1952-02-25 Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). CH311606A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH311606T 1952-02-25
CH307799T 1952-11-25

Publications (1)

Publication Number Publication Date
CH311606A true CH311606A (en) 1955-11-30

Family

ID=25735339

Family Applications (1)

Application Number Title Priority Date Filing Date
CH311606D CH311606A (en) 1952-02-25 1952-02-25 Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).

Country Status (1)

Country Link
CH (1) CH311606A (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10780083B1 (en) 2019-03-11 2020-09-22 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10786485B1 (en) 2019-03-11 2020-09-29 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10842798B1 (en) 2019-11-06 2020-11-24 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10927096B2 (en) 2019-03-11 2021-02-23 Nocion Therapeutics, Inc. Ester substituted ion channel blockers and methods for use
US10934263B2 (en) 2019-03-11 2021-03-02 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10933055B1 (en) 2019-11-06 2021-03-02 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10968179B2 (en) 2019-03-11 2021-04-06 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US11332446B2 (en) 2020-03-11 2022-05-17 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11512058B2 (en) 2019-03-11 2022-11-29 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10786485B1 (en) 2019-03-11 2020-09-29 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10828287B2 (en) 2019-03-11 2020-11-10 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10780083B1 (en) 2019-03-11 2020-09-22 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10927096B2 (en) 2019-03-11 2021-02-23 Nocion Therapeutics, Inc. Ester substituted ion channel blockers and methods for use
US10934263B2 (en) 2019-03-11 2021-03-02 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US11643404B2 (en) 2019-03-11 2023-05-09 Nocion Therapeutics, Inc. Ester substituted ion channel blockers and methods for use
US10968179B2 (en) 2019-03-11 2021-04-06 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US11603355B2 (en) 2019-03-11 2023-03-14 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US11377422B2 (en) 2019-03-11 2022-07-05 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10842798B1 (en) 2019-11-06 2020-11-24 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10933055B1 (en) 2019-11-06 2021-03-02 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US11696912B2 (en) 2019-11-06 2023-07-11 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US11332446B2 (en) 2020-03-11 2022-05-17 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use

Similar Documents

Publication Publication Date Title
CH311606A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311609A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311613A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311610A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311608A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311614A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311612A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311607A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311615A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311611A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311629A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311604A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311603A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH312572A (en) Process for the preparation of a new basic substituted fatty acid (2-halo-6-methyl) anilide
CH311621A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311605A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311630A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311632A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH328671A (en) Process for the production of a new basic substituted fatty acid-2-halogen-6-methyl-anilide
CH311644A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311619A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311631A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311620A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311639A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311624A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).